Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial of combination chemotherapy in patients with multiple myeloma and plasma cell neoplasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: The Cleveland Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED